Tag: continuous glucose monitor

December 18, 2018

Nemaura Publishes Positive Data from SugarBEAT FDA Clinical Trial

Nemaura Medical (NASDAQ:NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for...
November 20, 2018

Nemaura Signs License and Distribution Agreement for SugarBEAT Commercial Launch in Qatar

Nemaura Medical (NASDAQ:NMRD), a medical technology company developing sugarBEAT as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for...
November 8, 2018

Nemaura Develops Functionality for SugarBEAT

This additional development has added predictive algorithms and alarm purposes for users to monitor their insulin.
November 8, 2018

Nemaura Medical Reports Second Quarter 2018 Financial Results

Nemaura Medical (NASDAQ:NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for...
September 12, 2018

Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT FDA Clinical Trial

Nemaura Medical (NASDAQ:NMRD), a medical technology company developing sugarBEAT as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for...